91 – 100 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
The mind and the belly: a glance at how the nervous system directs metabolism
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.
(
- Contribution to journal › Article
-
Mark
Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors.
(
- Contribution to journal › Article
-
Mark
HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin.
(
- Contribution to journal › Article
-
Mark
Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
(
- Contribution to journal › Article
-
Mark
Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
(
- Contribution to journal › Scientific review